首页> 外文OA文献 >Bigger and Better? Representativeness of the Influenza A Surveillance Using One Consolidated Clinical Microbiology Laboratory Data Set as Compared to the Belgian Sentinel Network of Laboratories
【2h】

Bigger and Better? Representativeness of the Influenza A Surveillance Using One Consolidated Clinical Microbiology Laboratory Data Set as Compared to the Belgian Sentinel Network of Laboratories

机译:更大,更好?与比利时哨兵网络的实验室相比,使用一种综合的临床微生物实验室数据集的甲型流感的表现性

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Infectious diseases remain a serious public health concern globally, while the need for reliable and representative surveillance systems remains as acute as ever. The public health surveillance of infectious diseases uses reported positive results from sentinel clinical laboratories or laboratory networks, to survey the presence of specific microbial agents known to constitute a threat to public health in a given population. This monitoring activity is commonly based on a representative fraction of the microbiology laboratories nationally reporting to a single central reference point. However, in recent years a number of clinical microbiology laboratories (CML) have undergone a process of consolidation involving a shift toward laboratory amalgamation and closer real-time informational linkage. This report aims to investigate whether such merging activities might have a potential impact on infectious diseases surveillance. Influenza data was used from Belgian public health surveillance 2014–2017, to evaluate whether national infection trends could be estimated equally as effectively from only just one centralized CML serving the wider Brussels area (LHUB-ULB). The overall comparison reveals that there is a close correlation and representativeness of the LHUB-ULB data to the national and international data for the same time periods, both on epidemiological and molecular grounds. Notably, the effectiveness of the LHUB-ULB surveillance remains partially subject to local regional variations. A subset of the Influenza samples had their whole genome sequenced so that the observed epidemiological trends could be correlated to molecular observations from the same period, as an added-value proposition. These results illustrate that the real-time integration of high-throughput whole genome sequencing platforms available in consolidated CMLs into the public health surveillance system is not only credible but also advantageous to use for future surveillance and prediction purposes. This can be most effective when implemented for automatic detection systems that might include multiple layers of information and timely implementation of control strategies.
机译:传染病在全球范围内仍然是一个严重的公共卫生问题,而对可靠和代表性监测系统的需求仍然是急性的。传染病的公共卫生监测用来使用Sentinel临床实验室或实验网络的阳性结果,调查已知对特定人群的公共卫生构成威胁的特异性微生物剂的存在。该监测活动通常基于微生物实验室的代表性分数,对单一的中央参考点进行全国报告。然而,近年来许多临床微生物学实验室(CML)经历了涉及转向实验室合并和更接近实时信息联系的过程的整合过程。本报告旨在调查这种合并活动是否可能对传染病监测产生潜在影响。流感数据来自比利时公共卫生监测2014 - 2017年,以评估国家感染趋势是否可以同样有效地估计,只有一个用于更广泛的布鲁塞尔地区(LHUB-ULB)的一个集中式CML。整体比较揭示了LHUB-ULB数据对国家和国际数据的密切相关性和代表在流行病学和分子场上的同一时间段内。值得注意的是,LHUB-ULB监测的有效性仍然部分受到当地区域变异的影响。流感样本的子集具有它们的全基因组测序,使得观察到的流行病学趋势可以与同一时期的分子观察相关,作为增加值的主张。这些结果表明,在公共卫生监测系统中,高通量全基因组测序平台的高通量全基因组测序平台不仅可信,而且有利于用于将来监视和预测目的。当为自动检测系统实现时,这可以是最有效的,该系统可能包括多层信息并及时实现控制策略。

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号